Gene · 2268
Papers1,862
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,862
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune-Related Genes can Serve as Potential Biomarkers for Predicting Severe Acute Pancreatitis. | Horm Metab Res | 2023 | 37391177 | PubTator, text mining | PubMed |
| Exploring the link between viruses and cancer in companion animals: a comprehensive and comparative analysis. | Infect Agent Cancer | 2023 | 37386451 | PubTator, text mining | PubMed |
| Acute myeloid leukemia cells and MSC-derived exosomes inhibiting transformation in myelodysplastic syndrome. | Discov Oncol | 2023 | 37382733 | PubTator, text mining | PubMed |
| ZIKV Strains Elicit Different Inflammatory and Anti-Viral Responses in Microglia Cells. | Viruses | 2023 | 37376550 | PubTator, text mining | PubMed |
| Integrated Single-Cell and Transcriptome Sequencing Analyses Identify Dipeptidase 2 as an Immune-Associated Prognostic Biomarker for Lung Adenocarcinoma. | Pharmaceuticals (Basel) | 2023 | 37375818 | PubTator, text mining | PubMed |
| NOTCH Signaling in Mantle Cell Lymphoma: Biological and Clinical Implications. | Int J Mol Sci | 2023 | 37373427 | PubTator, text mining | PubMed |
| Upregulated Expression of ERBB2/HER2 in Multiple Myeloma as a Predictor of Poor Survival Outcomes. | Int J Mol Sci | 2023 | 37373090 | PubTator, text mining | PubMed |
| Aligning the Global Delta Risk Index with SDG and SFDRR global frameworks to assess risk to socio-ecological systems in river deltas. | Sustain Sci | 2023 | 37363314 | PubTator, text mining | PubMed |
| Src- and Abl-family kinases activate spleen tyrosine kinase to maximize phagocytosis and Leishmania infection. | J Cell Sci | 2023 | 37357611 | PubTator, text mining | PubMed |
| Integrating host transcriptomic signatures for distinguishing autoimmune encephalitis in cerebrospinal fluid by metagenomic sequencing. | Cell Biosci | 2023 | 37332019 | PubTator, text mining | PubMed |
Pyoderma gangrenosum following anti-TNF therapy in chronic recurrent multifocal osteomyelitis: drug reaction or cutaneous manifestation of the disease? A critical review on the topic with an emblematic case report. | Front Med (Lausanne) | 2023 | 37324147 | PubTator, text mining | PubMed |
| Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy? | Front Mol Neurosci | 2023 | 37305556 | PubTator, text mining | PubMed |
| Bioinformatics analysis reveals the landscape of immune cell infiltration and novel immune-related biomarkers in moyamoya disease. | Front Genet | 2023 | 37265961 | PubTator, text mining | PubMed |
| Pan-cancer Analysis Reveals SRC May Link Lipid Metabolism and Macrophages. | Iran J Biotechnol | 2023 | 37228626 | PubTator, text mining | PubMed |
| Uncovering transcriptomic landscape alterations of CAN-2409 in in vitro and in vivo glioma models. | Front Med (Lausanne) | 2023 | 37228396 | PubTator, text mining | PubMed |
| RUNX1 colludes with NOTCH1 to reprogram chromatin in T cell acute lymphoblastic leukemia. | iScience | 2023 | 37213235 | PubTator, text mining | PubMed |
| New small molecules in dermatology: for the autoimmunity, inflammation and beyond. | Inflamm Res | 2023 | 37212867 | PubTator, text mining | PubMed |
| Targeting the Src N-terminal regulatory element in cancer. | Oncotarget | 2023 | 37204272 | PubTator, text mining | PubMed |
| Immune characteristics and genetic markers of esophageal cancer by single-cell analysis: implications for immunotherapy. | J Thorac Dis | 2023 | 37197539 | PubTator, text mining | PubMed |
| Discovery of Novel Bruton's Tyrosine Kinase PROTACs with Enhanced Selectivity and Cellular Efficacy. | J Med Chem | 2023 | 37195170 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2268/papers?page=9